Add to ORKGIntroduction: Large-panel genomic tumor testing (GTT) is a new technology that promises to make cancer treatment more precise, but that currently poses many uncertainties regarding its clinical value and appropriate use. Uncertainty Tolerance (UT), a psychological construct that describes trait-level differences in individuals’ responses to uncertainty, may influence oncologists’ perceptions and attitudes regarding GTT
Pre-test counseling about multigene panel testing involves many uncertainties. Ideally, counselees a...
Our study examined whether patient characteristics, beliefs, and decision-making styles were associa...
Multigene panel testing is mainly used to improve identification of genetic causes in families with ...
Novel medical technologies, like large-panel genomic tumor testing (GTT), offer great promise but al...
PURPOSE: Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but un...
Background: • Genomic tumor testing (GTT) is a new technology and a cornerstone of the “precision me...
Abstract Purpose Large-panel genomic tumor testing (G...
OBJECTIVE: To compare clinicians\u27 and patients\u27 preferences for disclosure of genomic tumor te...
Large-panel genomic tumor testing (GTT) is an emerging technology that promises to make cancer treat...
Background: Many clients who undergo genetic testing (GT) for cancer risk assessment receive variant...
Background: Large-panel genomic tumor testing (GTT) is a new technology that promises to make cancer...
Reducing cancer-related uncertainty is a motivating factor for accessing genetic testing, such as te...
We sought to examine how patients’ treatment decisions incorporate potentially conflicting informati...
This paper explores clinicians’ and scientists’ accounts of genomic research in cancer care and the ...
This paper explores clinicians’ and scientists’ accounts of genomic research in cancer care and the ...
Pre-test counseling about multigene panel testing involves many uncertainties. Ideally, counselees a...
Our study examined whether patient characteristics, beliefs, and decision-making styles were associa...
Multigene panel testing is mainly used to improve identification of genetic causes in families with ...
Novel medical technologies, like large-panel genomic tumor testing (GTT), offer great promise but al...
PURPOSE: Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but un...
Background: • Genomic tumor testing (GTT) is a new technology and a cornerstone of the “precision me...
Abstract Purpose Large-panel genomic tumor testing (G...
OBJECTIVE: To compare clinicians\u27 and patients\u27 preferences for disclosure of genomic tumor te...
Large-panel genomic tumor testing (GTT) is an emerging technology that promises to make cancer treat...
Background: Many clients who undergo genetic testing (GT) for cancer risk assessment receive variant...
Background: Large-panel genomic tumor testing (GTT) is a new technology that promises to make cancer...
Reducing cancer-related uncertainty is a motivating factor for accessing genetic testing, such as te...
We sought to examine how patients’ treatment decisions incorporate potentially conflicting informati...
This paper explores clinicians’ and scientists’ accounts of genomic research in cancer care and the ...
This paper explores clinicians’ and scientists’ accounts of genomic research in cancer care and the ...
Pre-test counseling about multigene panel testing involves many uncertainties. Ideally, counselees a...
Our study examined whether patient characteristics, beliefs, and decision-making styles were associa...
Multigene panel testing is mainly used to improve identification of genetic causes in families with ...